- Peganone is a member of the hydantoin series.
- Peganone is available in dosage strength of 250 mg.
Indication
PEGANONE is indicated for the control of tonic-clonic (grand-mal) and complex (psychomotor) seizures.
Important Safety Information
PEGANONE is contraindicated in patients with hepatic abnormalities or hematologic disorders.
Antiepileptic drugs (AEDs), including PEGANONE, increase the risk of suicidal thoughts or behavior. Patients should be monitored for the emergence or worsening of depression, or suicidal thoughts or behavior.
PEGANONE can cause fetal harm including neonatal coagulation defect. Use during pregnancy can result in an increased incidence of birth defects. Antiepileptic drugs should not be discontinued because of the strong possibility of precipitating status epilepticus with attendant hypoxia and risk to both mother and the unborn child.
Blood dyscrasias have been reported in patients receiving PEGANONE. Isolated cases of lymphadenopathy and systemic lupus erythromatosus have occurred with PEGANONE.
For more information, please see Full Prescribing Information.
® Trademark of Lundbeck Inc., Deerfield, IL 60015, U.S.A.
Important Contact Information
Dial 911 if you are experiencing a medical emergency. Please visit Customer Support for important contact information relating to our products, including:
- Medical information
- Drug safety information
- Product ordering information
You are encouraged to report negative side effects to the FDA.
Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.